Skip to content

A multicenter study on the application effect of remimazolam besylate in obese patients during the peri-anesthesia period

A multicenter study on the application effect of remimazolam besylate in obese patients during the peri-anesthesia period

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600121837
Enrollment
Unknown
Registered
2026-04-03
Start date
2026-04-03
Completion date
Unknown
Last updated
2026-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obese patients

Interventions

Control group:Propofol is used for induction and maintenance under general anesthesia
Experimental Group:General anesthesia induction and maintenance use of remimazolam

Sponsors

West China Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. 28 kg/m^2<= BMI <=40 kg/m^2; 2. Age: 18-65 years old, ASA classification: I - III; 3. General anesthesia surgery is planned and the operation time is expected to exceed 1 hour.

Exclusion criteria

Exclusion criteria: 1. Benzodiazepines, opioid analgesics and psychotropic drugs were taken within one month before the study; 2. Allergic to the drugs involved in the research; 3. Preoperative combined myasthenia gravis or severe liver and kidney dysfunction (defined as Child C liver function classification, creatinine clearance rate < 30ml/min).

Design outcomes

Primary

MeasureTime frame
The incidence of cardiac and pulmonary complications during hospitalization;Perioperative hypotensive events;

Secondary

MeasureTime frame
The differences in the evaluation indicators of the onset speed of drug sedation between the two groups of patients;The differences in drug safety evaluation indicators between the two groups of patients;Evaluation indicators of drug metabolism rate;The differences in the assessment indicators of drug sedation intensity between the two groups of patients include;

Countries

China

Contacts

Public ContactQian Li

West China Hospital of Sichuan University

hxliqian@foxmail.com+86 28 85421550

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 17, 2026